Dheerendra Prasad

Dr. Dheerendra Prasad

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Journal of Neurosurgery
Verified
Journal Article
Closed access
SGSharad Goyal
Sharad Goyal
DPDheerendra Prasad
Dheerendra Prasad
FHFrank Harrell
Frank Harrell
JMJulie Matsumoto
Julie Matsumoto
TRTyvin Rich
Tyvin Rich
LSLadislau Steiner
Ladislau Steiner
Object. The goal of this study was to evaluate the effectiveness and limitations of gamma knife surgery (GKS) in the treatment of intracranial breast carcinoma lesions. Methods. A retrospective analysis of the GKS database at the University of Virginia Health System identified 43 patients with a total of 84 lesions who were treated between 1989 and 2000. All patients who received treatment were included in this study. Imaging studies were available in 35 patients with 67 treated lesions. The overall duration of median survival was 13 months (95% confidence interval [CI] 7–16 months) after radiosurgery. A univariable Cox regression analysis revealed that a single lesion (p = 0.035), a high Karnofsky Performance Scale (KPS) score (p = 0.019), and a high Score Index for Radiosurgery (SIR) in Brain Metastases (p = 0.036) were associated with a significantly lengthened time to local treatment failure. The median duration of survival for patients grouped according to the SIR as low, middle, and high was 3, 8, a...

11 October 2017 in Stereotactic and Functional Neurosurgery
Verified
Journal Article
Closed access
CRCharlotte Rivers
Charlotte Rivers
MTMarissa Tranquilli
Marissa Tranquilli
SPShefalika Prasad
Shefalika Prasad
EWEvan Winograd
Evan Winograd
RPRobert J. Plunkett
Robert J. Plunkett
DPDheerendra Prasad
Dheerendra Prasad
Purpose/Objectives: The purpose of this study was to evaluate the effect of the number of brain lesions for which stereotactic radiosurgery (SRS) was performed on the dose volume relationships in normal brain. Materials and Methods: Brain tissue was segmented using the patient's pre-SRS MRI. For each plan, the following data points were recorded: total brain volume, number of lesions treated, volume of brain receiving 8 Gy (V8), V10, V12, and V15. Results: A total of 225 Gamma Knife® treatments were included in this retrospective analysis. The number of lesions treated ranged from 1 to 29. The isodose for prescription ranged from 40 to 95% (mean 55%). The mean prescription dose to tumor edge was 18 Gy. The mean coverage, selectivity, conformity, and gradient index were 97.5%, 0.63, 0.56, and 3.5, respectively. The mean V12 was 9.5 cm3 (ranging from 0.5 to 59.29). There was no correlation between the number of lesions and brain V8, V12, V10, or V15. There was a direct and statistically significant relationship between the brain volume treated (V8, V10, V12, and V15) and total volume of tumors treated (p < 0.001). In our study, the integral dose to the brain exceeded 3 J when the total tumor volume exceeded 25 cm3. Conclusions: The number of metastatic brain lesions treated bears no significant relationship to total brain tissue volume treated when using SRS. The fact that the integral dose to the brain exceeded 3 J when the total tumor volume exceeded 25 cm3 is useful for establishing guidelines. Although standard practice has favored using whole brain radiation therapy in patients with more than 4 lesions, a significant amount of normal brain tissue may be spared by treating these patients with SRS. SRS should be carefully considered in patients with multiple brain lesions, with the emphasis on total brain volume involved rather than the number of lesions to be treated.

30 April 2006 in Neurosurgery Clinics of North America
Verified
Journal Article
Closed access
DPDheerendra Prasad
Dheerendra Prasad

21 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
NANeil D. Almeida
Neil D. Almeida
CKCathleen Kuo
Cathleen Kuo
TSTyler Vincent Schrand
Tyler Vincent Schrand
JRJulia Rupp
Julia Rupp
VMVenkatesh S Madhugiri
Venkatesh S Madhugiri
DPDheerendra Prasad
Dheerendra Prasad
Background/Objectives: To determine the impact of stereotactic radiosurgery on outcomes of metastatic breast cancer with intracranial metastases. Methods: We systematically searched the PubMed and EMBASE databases for studies published between 1 January 1990 and 1 August 2024. Primary research articles evaluating the outcomes of stereotactic radiosurgery on intracranial metastases from breast cancer were included. Adverse events were defined as leptomeningeal disease, radiation necrosis, seizure, and headache. The pooled estimate was calculated using the DerSimonian and Laird approach. Results: Sixteen studies encompassing 1228 patients met the inclusion criteria. Our analysis revealed a median survival duration of 13.1 ± 3.8 months and a pooled 1-year overall survival rate of 53.1% after SRS treatment. There was a 29% local recurrence rate at 1 year and a 35% overall distant recurrence rate. In addition, our analysis found a relatively low rate of acute adverse events at 15.5%. Conclusions: SRS demonstrates promising efficacy and safety in managing intracranial metastases from breast cancer, with a favorable toxicity profile.

1 January 2015 in Surgical Neurology International
Verified
Journal Article
Open access
RFRobertA Fenstermaker
RobertA Fenstermaker
HSHakeem Shakir
Hakeem Shakir
JQJingxin Qiu
Jingxin Qiu
DPDheerendra Prasad
Dheerendra Prasad
LMLaszloL Mechtler
LaszloL Mechtler
Papillary tumor of the pineal region (PTPR) is a rare neoplasm with only anecdotal data to guide the treatment. Results of treatment with surgery, radiation therapy, and chemotherapy have been reported to have varying degrees of success. Here we report a patient with a PTPR, who underwent subtotal resection, gamma knife stereotactic radiosurgery, and adjuvant temozolomide chemotherapy. During 9 years of clinical and radiographic follow-up, the patient has had regression of residual tumor and remains asymptomatic. When gross total resection of a PTPR is not possible, treatment with gamma knife stereotactic radiosurgery and temozolomide chemotherapy may provide long-term tumor control.

18 October 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
VMVenkatesh S. Madhugiri
Venkatesh S. Madhugiri
DPDheerendra Prasad
Dheerendra Prasad